Muhammad Shabbir Rawala

Muhammad Shabbir Rawala

Auto-generated profile, based on publicly available information

Muhammad Shabbir Rawala

Department of Internal Medicine, WVU-Charleston Division, Charleston, WV, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2019 in European Journal of Gastroenterology & Hepatology
Verified
Journal Article
Closed access
MKMuhammad Y. Khan
Muhammad Y. Khan
AMAlbana B. Mihali
Albana B. Mihali
MRMuhammad S. Rawala
Muhammad S. Rawala
AAAysha Aslam
Aysha Aslam
WSWaqas J. Siddiqui
Waqas J. Siddiqui
Background: Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease worldwide. The pathogenesis of NAFLD is complex and multifactorial. There is growing evidence that altered gut microbiota plays a key role in NAFLD progression. Probiotics/synbiotics, by modifying gut microbiota, may be a promising treatment choice for NAFLD management. Aim: The aim of this study was to study the effect of probiotics/synbiotics on various laboratory and radiographic parameters in NAFLD management. Materials and methods: A systematic review and meta-analysis were carried out according to Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. We searched PubMed, Medline, and Google Scholar for randomized-controlled trials that studied the role of probiotics/synbiotics in NAFLD. The primary outcome was change in baseline alanine aminotransferase and aspartate aminotransferase in the treatment arm. We used a random-effects model and inverse variance for the continuous data to estimate the mean difference (MD) and the standard mean difference (SMD) in RevMan Version 5.3. Results: We included 12 randomized-controlled trials for analysis. The intervention arm, which comprised of the probiotic and/or the synbiotic arm, showed a significant improvement in alanine aminotransferase levels, MD=–13.93, confidence interval (CI)=–20.20 to –7.66, P value of less than 0.0001, I 2=92% and aspartate aminotransferase levels MD=−11.45, CI=−15.15 to −7.74, P value of less than 0.00001, I 2=91%. There was a reduction in high-sensitivity C-reactive protein levels in the intervention arm, SMD=–0.68, CI=–1.10 to –0.26, P value of 0.001, I 2=0%. The liver fibrosis score improved in the intervention arm, MD=–0.71, CI=–0.81 to –0.61, P value less than 0.00001, I 2=0%. Conclusion: Probiotic/synbiotic use improves aminotransaminase levels and reduces proinflammatory marker high-sensitivity C-reactive protein and liver fibrosis in NAFLD patients.

5 June 2019 in Cureus
Verified
Journal Article
Open access
PDF file
MKMuhammad Y. Khan
Muhammad Y. Khan
MRMuhammad Shabbir Rawala
Muhammad Shabbir Rawala
MSMaryam Siddiqui
Maryam Siddiqui
WAWaqas Abid
Waqas Abid
AAAysha Aslam
Aysha Aslam
Hyponatremia is a common clinical condition encountered in the hospital setting. Syndrome of inappropriate antidiuretic hormone (SIADH) is an important and one of the most common causes of hyponatremia. SIADH accounts for approximately one-third of all cases of hyponatremia. Tolvaptan is a vasopressin receptor antagonist used to treat SIADH. Hepatoxicity is a rare yet dangerous side effect from Tolvaptan use. We present a case of cholestatic liver injury in an elderly female who presented with hyponatremia. She received two doses of tolvaptan 15mg and developed worsening in her total bilirubin (T Bili) and alkaline phosphatase (Alk Phos) levels. Tolvaptan is known to cause elevated transaminase levels and the mechanism of action is thought to be idiosyncratic. Fortunately, the patient responded with an improvement in T Bili and Alk Phos levels after stopping tolvaptan. This case highlights the cautious use of tolvaptan in elderly patients with SIADH as even small doses can potentiate hepatotoxicity.

23 October 2018 in American Journal of Case Reports
Verified
Journal Article
Closed access
PDF file
MRMuhammad Shabbir Rawala
Muhammad Shabbir Rawala
VBVarun Badami
Varun Badami
SRSyed Bilal Rizvi
Syed Bilal Rizvi
ANAravinda Nanjundappa
Aravinda Nanjundappa
BACKGROUND:Hemetemesis is rarely caused by an aorta-esophageal fistula with thoracic aorta aneurysm in patients. This uncommon etiology, AEF/TAA, can potentially rupture and cause death if left untreated. Thoracic endovascular aorta repair places a s...

3 March 2020 in Journal of Community Hospital Internal Medicine Perspectives
Verified
Journal Article
Open access
MRMuhammad Shabbir Rawala
Muhammad Shabbir Rawala
AAAmna Saleem Ahmed
Amna Saleem Ahmed
KPKanna Posina
Kanna Posina
VSVarun Sundaram
Varun Sundaram
With the advent of medical technology, coronary angiography is a common practice to evaluate patient for coronary artery disease. Normally, patients undergoing angiogram receive antiplatelets, anticoagulants, and platelet aggregation inhibitor agents. Glycoprotein IIb/IIIa receptor inhibitors are a type of platelets antiaggregant agents that can cause severe thrombocytopenia in very few cases. We present a case of a 69-year-old female who presented with chest pain, underwent an angiography and had two stents placed. She was administered tirofiban during angiogram that caused acute severe thrombocytopenia decreasing her platelets count from 224 to 2 k/mm3 within 1 day. Patients platelets gradually recovered after trial of steroid and platelets transfusion. Antiplatelets (Aspirin and Clopidogrel) were resumed; however, patient’s platelets remained stable.

2 March 2019 in American Journal of Case Reports
Verified
Journal Article
Closed access
PDF file
MRMuhammad Shabbir Rawala
Muhammad Shabbir Rawala
MNMuhammad Muslim Noorani
Muhammad Muslim Noorani
RGRajat Gulati
Rajat Gulati
SWShamaiza Waqas
Shamaiza Waqas
DDDarshan Dave
Darshan Dave
BACKGROUND:Cerebral venous sinus thrombosis (CVST) is an uncommon cause of stroke. CVST can be caused by systemic conditions as well as mechanical factors that reduce blood flow to promote thrombosis. These can include hormonal therapies, pregnancy, ...

19 December 2018 in Case Reports in Cardiology
Verified
Journal Article
Open access
PDF file
MRMuhammad Shabbir Rawala
Muhammad Shabbir Rawala
SNS. Tahira Shah Naqvi
S. Tahira Shah Naqvi
KFKinaan Farhan
Kinaan Farhan
MYMuhammad Yasin
Muhammad Yasin
SRSyed Bilal Rizvi
Syed Bilal Rizvi
Congenital defects of the coronary arteries are noted in 0.2–1.4% of the general population. The first case of an anomalous origin of right coronary artery from pulmonary artery (ARCAPA) was described by Brooks in 1885. ARCAPA has an overall incidence of 0.002% in the general population. Most of the cases are asymptomatic; however, it can lead to serious complications such as heart failure, ischemia, and sudden death. A 57-year-old man presented to the cardiologist’s office with complaints of shortness of breath and fatigue. The patient also had a previous history of coronary stents and heart failure. Initially, he was evaluated with a stress test which was reported as abnormal. The patient then underwent an invasive coronary angiography that revealed anomalous origin of the right coronary artery (RCA) and multivessel disease. Cardiothoracic surgery evaluated the patient and coronary artery bypass graft was performed. During the surgery, the anomalous origin of RCA from the pulmonary artery was identified and was successfully corrected by reimplanting the RCA into the ascending aorta. The anomalous origin of RCA is a rare yet life-threatening condition. The RCA due to its location of origin from the pulmonary artery tends to be a low-pressure vessel with a very thin and fragile wall. It also serves as a retrograde venous conduit from the left coronary circulation into the pulmonary artery. This connection results in a left-to-right shunt that explains the increase in oxygen saturation in the pulmonary artery and the high cardiac output which is normally seen in these cases. The clinical presentation can vary from coronary ischemia to heart failure or sudden death. Therefore, surgical correction is recommended even in asymptomatic patients. We present a case of an anomalous origin of RCA from the pulmonary artery which, unlike the origin of left coronary from pulmonary artery, is very rare. Patients with this condition should have early correction even if they are asymptomatic in order to prevent long-term complications.